Cost-Effectiveness of Colorectal Cancer Surveillance in Hodgkin Lymphoma Survivors Treated with Procarbazine and/or Infradiaphragmatic Radiotherapy
Berbel L.M. Ykema(The Netherlands Cancer Institute), Iris Lansdorp‐Vogelaar(Erasmus University Rotterdam), Richard W.M. van der Maazen(Radboud University Nijmegen), Cécile P.M. Janus(Erasmus MC Cancer Institute), Lisanne S. Rigter(Dutch Cancer Society), Judith M. Roesink(University Medical Center Utrecht), Wieke H.M. Verbeek(Vrije Universiteit Amsterdam), Leon M.G. Moons(University Medical Center Utrecht), Manon C.W. Spaander(Erasmus University Rotterdam), Flora E. van Leeuwen(The Netherlands Cancer Institute), Eefke Petersen(University Medical Center Utrecht), Tanya M. Bisseling(Radboud University Nijmegen), Monique E. van Leerdam(Leiden University Medical Center), Andrea Gini, Pieternella J. Lugtenburg(Erasmus MC Cancer Institute), Jan Paul de Boer, Gerrit A. Meijer(The Netherlands Cancer Institute), Beatriz Carvalho(Centro Universitário das Faculdades Metropolitanas Unidas), Pétur Snæbjörnsson(University of Iceland), Berthe M.P. Aleman(The Netherlands Cancer Institute)
Cited by 4
Related Papers
2022 ESC Guidelines on cardio-oncology developed in collaboration with the European Hematology Association (EHA), the European Society for Therapeutic Radiology and Oncology (ESTRO) and the International Cardio-Oncology Society (IC-OS)
|European Heart Journal|2022|2.7k
AACR Project GENIE: Powering Precision Medicine through an International Consortium
|Cancer Discovery|2017|2k
Pembrolizumab versus methotrexate, docetaxel, or cetuximab for recurrent or metastatic head-and-neck squamous cell carcinoma (KEYNOTE-040): a randomised, open-label, phase 3 study
|The Lancet|2018|1.7k
Genome-wide cell-free DNA fragmentation in patients with cancer
|Nature|2019|1.5k
Direct detection of early-stage cancers using circulating tumor DNA
|Science Translational Medicine|2017|1.1k